MULTICENTER CONTROLLED RANDOMIZED DOUBLE-BLIND PLACEBO STUDY OF MINAPRINE IN ELDERLY PATIENTS SUFFERING FROM PROLONGED DEPRESSIVE REACTION

被引：8

作者：

PARNETTI, L

SOMMACAL, S

LABATE, AMM

SENIN, U

机构：

[1] Gerontologia E Geriatria, E Centro Ricerche Gerontologiche, Università Degli Studi di Perugia, Dipartimento di Medicina Clinica, Patologia E Farmacologia, Perugia, 06122, via Eugubina

[2] Sanofi-Winthrop, Milan

[3] Istituto di Clinica Medica E Gastroenterologia, University of Bologna, Bologna

来源：

DRUG INVESTIGATION | 1993年 / 6卷 / 04期

关键词：

D O I：

10.1007/BF03259242

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A multicentre randomised double-blind controlled study using minaprine vs placebo was carried out in 130 elderly patients suffering from prolonged depressive reaction (ICD 9, 309. 1). After a 15-day run-in period, either oral minaprine 100mg twice daily or placebo was given for 90 days (double-blind period) and then both groups were treated with minaprine at the same dosage (open period). Depressive symptoms were assessed by means of the 'Evaluation Clinique de la Personnalite' scale and the Symptom Rating Test. At the end of the double-blind period, the minaprine group showed improvement in the majority of psychological parameters, while after the open period the 'ex-placebo group' showed a more pronounced improvement, reaching approximately the same level as the minaprine group. Tolerability was highly satisfactory in both groups. The high frequency and clinical relevance of depression due to stressful events in the elderly supports the therapeutic value of minaprine, an atypical antidepressant agent devoid of anticholinergic effects.

引用

页码：181 / 188

页数：8

共 23 条

[1]

Alexopoulos G.S., Biological abnormalities in late-life depression, Journal of Geriatric Psychiatry, 22, pp. 25-35, (1989)

[2]

Aterdam J.D., Dunner D.L., Fabre L.F., Kiev A., Rush A.J., Et al., Double-blind placebo-controlled, fixed dose trial of minaprine in patients with major depression, Pharmacopsychiatry, 22, pp. 137-143, (1989)

[3]

Anisman H., Zacharko R.M., Multiple neurochemical and behavioral consequences of Stressors: implications for depression, Pharmacology and Therapeutics, 46, pp. 119-136, (1990)

[4]

Biziere K., Kan J.P., Souilhac J., Muyard J.P., Roncucci R., Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug, Arzneimittel-Forschung — Drug Research, 32, pp. 824-831, (1982)

[5]

Biziere K., Wor P., Kan J.P., Mandel P., Garattini S., Et al., Minaprine, a new drug with antidepressant properties, International Journal of Drugs under Experimental and Clinical Research, 2, pp. 831-840, (1985)

[6]

Blazer D., Hughes D.C., George L.K., The epidemiology of depression in an elderly community population, Gerontologist, 27, pp. 281-287, (1987)

[7]

Bohacek N., Ravic M., Biziere K., Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study, International Journal of Drugs under Experimental and Clinical Research, 13, pp. 435-442, (1987)

[8]

Crea L., Donelli E., Sommacal S., Chierichetti S.M., Rapisarda V., Studio controllato in doppio cieco verso clorimipramina e verso placebo in pazienti affetti da disturbo distimico (DSM III), Progressi in Psichiatria, pp. 229-238, (1989)

[9]

Del Zompo M., Bernardi F., Burrai C., Bocchetta A., A double-blind study of minaprine versus amitriptyline in major depression, Neuropsychobiology, 24, pp. 79-83, (1990)

[10]

Folstein M.F., Folstein S.E., McHugh P.R., Mini Mental State: a practical method for grading the cognitive state of patients for the clinician, Journal of Psychiatric Research, 12, pp. 189-198, (1975)

← 1 2 3 →